Genetic Variants in Interleukin-10 Gene Association with Susceptibility and Cervical Cancer Development: A Case Control Study

Genetic Variants in Interleukin-10 Gene Association with Susceptibility and Cervical Cancer Development: A Case Control Study

Objectives Cervical cancer (CC) is one of the most destructive disease caused by persistent HPV infection which affects women worldwide, especially in developing countries. The genetic basis of host immune response especially cytokine function has been shown to influence CC susceptibility. Studies h...

Full description

Bibliographic Details
Main Authors:	Pushpendra D. Pratap, Syed Tasleem Raza, Ghazala Zaidi, Shipra Kunwar, Sharique Ahmad, Mark Rector Charles, Ale Eba, Muneshwar Rajput
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2022-06-01
Series:	Global Medical Genetics
Subjects:	human papillomavirus cervical cancer gene polymorphism
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0042-1743262

Similar Items

Evaluation of the Association between Genetic Polymorphism of Interleukin-1 Beta (–511C/T and +3953C/T) and Cervical Cancer Susceptibility
by: Pushpendra D. Pratap, et al.

The Impact of HPV Vaccination on Cervical Cancer in adolescent females: A narrative review
by: Vijay Bhalerao, et al.
Published: (2024-11-01)

MicroRNAs and their Role in the Pathogenesis of Cervical Cancer
by: Ale Eba, et al.
Published: (2016-10-01)

Identification of Genetic Variants of Human Papillomavirus in a Group of Mexican HIV/AIDS Patients and Their Possible Association with Cervical Cancer
by: FELIPE ORTIZ-GUTIÉRREZ, et al.
Published: (2021-12-01)

DEFB1 polymorphisms are involved in susceptibility to human papillomavirus infection in Brazilian gynaecological patients
by: Ludovica Segat, et al.
Published: (2014-11-01)

Diagnostic markers of human papillomavirus persistence and progression of cervical intraepithelial neoplasia
by: O. V. Khoperskaya, et al.
Published: (2022-01-01)

High SOX2 expression as an indicator of the potential involvement of cancer stem cells in the development of cervical cancer among females with HPV infection
by: E. Kldiashvili, et al.
Published: (2021-09-01)

Analysis of human papillomavirus type 16 E4, E5 and L2 gene variations among women with cervical infection in Xinjiang, China
by: Haozheng Cheng, et al.
Published: (2024-07-01)

Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review
by: Rita Medeiros, et al.
Published: (2020-03-01)

Genetic variations in E6, E7 and the long control region of human papillomavirus type 16 among patients with cervical lesions in Xinjiang, China
by: Xiangyi Zhe, et al.
Published: (2019-03-01)

Human papillomavirus infections among women with cervical lesions and cervical cancer in Yueyang, China: a cross-sectional study of 3674 women from 2019 to 2022
by: Min Zeng, et al.
Published: (2023-11-01)

Association of HLA-G 3′ UTR polymorphism and expression with the progression of cervical lesions in human papillomavirus 18 infections
by: Hui-Hui Xu, et al.
Published: (2018-12-01)

HPV-associated cervical diseases: screening, methods of examination, principles of treatment
by: Vera N Prilepskaya
Published: (2019-06-01)

Age-related Features of the Cytological Diagnosis of Cervical Dysplasia of Different Degrees
by: Maria Kirillina, et al.
Published: (2019-12-01)

What a patient needs to know about the virus human papillomas and cervical cancer?
by: Sergei P. Sinchikhin, et al.
Published: (2021-03-01)

An overview of cervical cancer epidemiology and prevention in the Baltic States
by: Una Kojalo, et al.
Published: (2023-04-01)

MicroRNA, HPV AND CERVICAL CARCINOGENESIS: MOLECULAR ASPECTS AND PROSPECTS OF CLINICAL APPLICATION
by: P. A. Arkhangelskaya, et al.
Published: (2016-10-01)

Biomarkers in Cervical Cancer
by: Eun-Kyoung Yim, et al.
Published: (2006-01-01)

Distribution of Human Papilloma Virus (HPV) in Cervical Adenocarcinoma and Adenosquamous Carcinoma
by: Gondo Mastutik, et al.
Published: (2021-06-01)

Human Papillomavirus Vaccine for Cervical Cancer: Where Are We Now?
by: Wen-Fang Cheng
Published: (2005-09-01)

Cervical cancer microbiome analysis: comparing HPV 16 and 18 with other HPV types
by: Maire Hidjo, et al.
Published: (2024-09-01)

The interplay between human papillomavirus and vaginal microbiota in cervical cancer development
by: Kimia Sharifian, et al.
Published: (2023-04-01)

Molecular Identification Of Human Papilloma Virus Genotypes In Patients With Cervical Cancer
by: Juan Carlos Piña Napal, et al.
Published: (2019-05-01)

Implications of Persistent HPV52 and HPV58 Positivity for the Management of Cervical Lesions
by: Baozhu Yi, et al.
Published: (2022-05-01)

The sensitivity of the pathogenic microflora of the cervical canal to antibiotics in patients with chronic cervicitis and human papilloma virus
by: T Yu Pestrikova, et al.
Published: (2015-02-01)

HPV 18 variants in women with cervical cancer in Northeast Brazil
by: Gerusinete Rodrigues Bastos dos Santos, et al.
Published: (2023-01-01)

Human papillomavirus vaccination: An important tool in cervical cancer elimination
by: Veena Pampapati, et al.
Published: (2020-01-01)

Human Papillomavirus Knowledge and Cervical Cancer Screening Practice among Uzbekistan Women
by: Erdenetuya Bolormaa, et al.
Published: (2023-01-01)

Relationship between awareness of cervical cancer and HPV infection and attitudes towards HPV vaccine among women aged 15-49 years: a cross-sectional study
by: Engin Yurtçu, et al.
Published: (2022-04-01)

COEXISTANCE OF CERVICAL CANCER AND MISSED ABORTION
by: А. L. Chernyshova, et al.
Published: (2016-02-01)

Vaccination as an effective method of prevention for cervical diseases associated with human papillomavirus (literature review)
by: Vera N Prilepskaya, et al.
Published: (2019-04-01)

Detection of human Papillomavirus 18 in cervical cancer samples using PCR-ELISA (DIAPOPS)
by: N Raji, et al.
Published: (2011-12-01)

Cervical cancer: monitoring of the main indicators characterizing this pathology in Khabarovsk Krai (2009–2019)
by: Tatyana Yu. Pestrikova, et al.
Published: (2021-05-01)

Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease
by: Serrano Beatriz, et al.
Published: (2012-12-01)

Analysis of HPV genotype differences in different stages of cervical intraepithelial neoplasia
by: YU Jingmin, et al.
Published: (2024-11-01)

Distribution of human papillomavirus in precancerous and cancerous cervical neoplasia in Tunisian women
by: Rahima Bel Haj Rhouma, et al.
Published: (2021-07-01)

Polymorphisms of the interleukin‐6 (IL‐6) gene contribute to cervical cancer susceptibility in Bangladeshi women: A case‐control study
by: Monishita Shaswati, et al.
Published: (2023-05-01)

Evaluation of colposcopy after the addition of human papillomavirus testing to the Turkish cervical cancer screening program
by: Ali Can Gunes, et al.
Published: (2023-12-01)

The role of antioxidants and the risk of human papillomavirus infection and cervical intraepithelial neoplasia: A systematic review
by: Leila Alizadeh, et al.
Published: (2023-03-01)

Diagnosis of cervical cancer by a urine test
by: Anna Małgorzata Łopuszyńska, et al.
Published: (2019-08-01)